To improve the comprehension of the pharmacological targeting of Eph receptors in prostate cancer, we designed and performed a set of experiments aimed at assessing the efficacy of Eph antagonism in a xenograft murine model of prostate cancer based on PC3 cells. Here, EPHA1 is linked to prostate cancer.